Logo image of SYENS.BR

SYENSQO SA (SYENS.BR) Stock Fundamental Analysis

EBR:SYENS - Euronext Brussels - BE0974464977 - Common Stock - Currency: EUR

65.48  -1.26 (-1.89%)

Fundamental Rating

3

Overall SYENS gets a fundamental rating of 3 out of 10. We evaluated SYENS against 67 industry peers in the Chemicals industry. SYENS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SYENS has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

SYENS had positive earnings in the past year.
In the past year SYENS had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: SYENS reported negative net income in multiple years.
Each year in the past 5 years SYENS had a positive operating cash flow.
SYENS.BR Yearly Net Income VS EBIT VS OCF VS FCFSYENS.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

1.2 Ratios

The Return On Assets of SYENS (-0.89%) is worse than 61.19% of its industry peers.
With a Return On Equity value of -1.50%, SYENS is not doing good in the industry: 61.19% of the companies in the same industry are doing better.
SYENS has a Return On Invested Capital of 4.59%. This is in the better half of the industry: SYENS outperforms 62.69% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SYENS is in line with the industry average of 6.51%.
Industry RankSector Rank
ROA -0.89%
ROE -1.5%
ROIC 4.59%
ROA(3y)2.81%
ROA(5y)0.13%
ROE(3y)7.26%
ROE(5y)-1.97%
ROIC(3y)8.47%
ROIC(5y)7.63%
SYENS.BR Yearly ROA, ROE, ROICSYENS.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

SYENS's Operating Margin of 9.06% is fine compared to the rest of the industry. SYENS outperforms 68.66% of its industry peers.
SYENS's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 31.61%, SYENS perfoms like the industry average, outperforming 46.27% of the companies in the same industry.
In the last couple of years the Gross Margin of SYENS has remained more or less at the same level.
Industry RankSector Rank
OM 9.06%
PM (TTM) N/A
GM 31.61%
OM growth 3Y-4.48%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.24%
GM growth 5YN/A
SYENS.BR Yearly Profit, Operating, Gross MarginsSYENS.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 10 -10 20 -20 30

More info and screens

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SYENS is creating some value.
The number of shares outstanding for SYENS has been reduced compared to 1 year ago.
Compared to 1 year ago, SYENS has an improved debt to assets ratio.
SYENS.BR Yearly Shares OutstandingSYENS.BR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SYENS.BR Yearly Total Debt VS Total AssetsSYENS.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

SYENS has an Altman-Z score of 2.25. This is not the best score and indicates that SYENS is in the grey zone with still only limited risk for bankruptcy at the moment.
SYENS has a Altman-Z score (2.25) which is in line with its industry peers.
The Debt to FCF ratio of SYENS is 23.55, which is on the high side as it means it would take SYENS, 23.55 years of fcf income to pay off all of its debts.
SYENS has a Debt to FCF ratio (23.55) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.25 indicates that SYENS is not too dependend on debt financing.
The Debt to Equity ratio of SYENS (0.25) is better than 67.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 23.55
Altman-Z 2.25
ROIC/WACC0.67
WACC6.81%
SYENS.BR Yearly LT Debt VS Equity VS FCFSYENS.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

A Current Ratio of 1.58 indicates that SYENS should not have too much problems paying its short term obligations.
SYENS has a Current ratio (1.58) which is in line with its industry peers.
SYENS has a Quick Ratio of 1.58. This is a bad value and indicates that SYENS is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of SYENS (0.96) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 0.96
SYENS.BR Yearly Current Assets VS Current LiabilitesSYENS.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

2

3. Growth

3.1 Past

The earnings per share for SYENS have decreased strongly by -102.63% in the last year.
SYENS shows a decrease in Revenue. In the last year, the revenue decreased by -3.10%.
Measured over the past years, SYENS shows a small growth in Revenue. The Revenue has been growing by 4.31% on average per year.
EPS 1Y (TTM)-102.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-35.14%
Revenue 1Y (TTM)-3.1%
Revenue growth 3Y4.31%
Revenue growth 5YN/A
Sales Q2Q%-0.31%

3.2 Future

Based on estimates for the next years, SYENS will show a small growth in Earnings Per Share. The EPS will grow by 7.94% on average per year.
Based on estimates for the next years, SYENS will show a small growth in Revenue. The Revenue will grow by 3.14% on average per year.
EPS Next Y6.78%
EPS Next 2Y12%
EPS Next 3Y12.22%
EPS Next 5Y7.94%
Revenue Next Year1.22%
Revenue Next 2Y2.83%
Revenue Next 3Y3.48%
Revenue Next 5Y3.14%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SYENS.BR Yearly Revenue VS EstimatesSYENS.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B
SYENS.BR Yearly EPS VS EstimatesSYENS.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 13.79 indicates a correct valuation of SYENS.
Compared to the rest of the industry, the Price/Earnings ratio of SYENS indicates a rather cheap valuation: SYENS is cheaper than 80.60% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of SYENS to the average of the S&P500 Index (27.15), we can say SYENS is valued slightly cheaper.
The Price/Forward Earnings ratio is 9.91, which indicates a very decent valuation of SYENS.
Based on the Price/Forward Earnings ratio, SYENS is valued cheaply inside the industry as 89.55% of the companies are valued more expensively.
SYENS is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.60, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.79
Fwd PE 9.91
SYENS.BR Price Earnings VS Forward Price EarningsSYENS.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

SYENS's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. SYENS is cheaper than 79.10% of the companies in the same industry.
SYENS's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 77.66
EV/EBITDA 6.16
SYENS.BR Per share dataSYENS.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SYENS does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as SYENS's earnings are expected to grow with 12.22% in the coming years.
PEG (NY)2.03
PEG (5Y)N/A
EPS Next 2Y12%
EPS Next 3Y12.22%

More info and screens

1

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.71%, SYENS has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.08, SYENS has a dividend in line with its industry peers.
Compared to the average S&P500 Dividend Yield of 2.42, SYENS is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.71%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
SYENS.BR Yearly Dividends per shareSYENS.BR Yearly Dividends per shareYearly Dividends per share 2024 2025 0.5 1 1.5

5.3 Sustainability

SYENS has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-157.41%
EPS Next 2Y12%
EPS Next 3Y12.22%
SYENS.BR Yearly Income VS Free CF VS DividendSYENS.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 500M -500M -1B

More info and screens

SYENSQO SA

EBR:SYENS (6/30/2025, 7:00:00 PM)

65.48

-1.26 (-1.89%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-15 2025-05-15/bmo
Earnings (Next)07-31 2025-07-31
Inst Owners23.15%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap6.83B
Analysts79.29
Price Target84.21 (28.6%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.71%
Yearly Dividend1.63
Dividend Growth(5Y)N/A
DP-157.41%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-21.73%
Min EPS beat(2)-38.67%
Max EPS beat(2)-4.8%
EPS beat(4)0
Avg EPS beat(4)-15.85%
Min EPS beat(4)-38.67%
Max EPS beat(4)-4.8%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.74%
Min Revenue beat(2)-2.18%
Max Revenue beat(2)-1.3%
Revenue beat(4)0
Avg Revenue beat(4)-2.99%
Min Revenue beat(4)-4.61%
Max Revenue beat(4)-1.3%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.2%
PT rev (3m)-12.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-22.74%
EPS NY rev (1m)0%
EPS NY rev (3m)-12.43%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.77%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.58%
Valuation
Industry RankSector Rank
PE 13.79
Fwd PE 9.91
P/S 1
P/FCF 77.66
P/OCF 8.84
P/B 0.95
P/tB 2.23
EV/EBITDA 6.16
EPS(TTM)4.75
EY7.25%
EPS(NY)6.61
Fwd EY10.1%
FCF(TTM)0.84
FCFY1.29%
OCF(TTM)7.41
OCFY11.31%
SpS65.17
BVpS69.12
TBVpS29.33
PEG (NY)2.03
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.89%
ROE -1.5%
ROCE 6.12%
ROIC 4.59%
ROICexc 4.89%
ROICexgc 8.72%
OM 9.06%
PM (TTM) N/A
GM 31.61%
FCFM 1.29%
ROA(3y)2.81%
ROA(5y)0.13%
ROE(3y)7.26%
ROE(5y)-1.97%
ROIC(3y)8.47%
ROIC(5y)7.63%
ROICexc(3y)9.08%
ROICexc(5y)8.08%
ROICexgc(3y)19%
ROICexgc(5y)18.92%
ROCE(3y)11.29%
ROCE(5y)10.17%
ROICexcg growth 3Y-19.3%
ROICexcg growth 5YN/A
ROICexc growth 3Y-9.3%
ROICexc growth 5YN/A
OM growth 3Y-4.48%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.24%
GM growth 5YN/A
F-Score5
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 23.55
Debt/EBITDA 1.3
Cap/Depr 91.58%
Cap/Sales 10.07%
Interest Coverage 250
Cash Conversion 56.67%
Profit Quality N/A
Current Ratio 1.58
Quick Ratio 0.96
Altman-Z 2.25
F-Score5
WACC6.81%
ROIC/WACC0.67
Cap/Depr(3y)98.43%
Cap/Depr(5y)76.05%
Cap/Sales(3y)9.47%
Cap/Sales(5y)8.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-102.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-35.14%
EPS Next Y6.78%
EPS Next 2Y12%
EPS Next 3Y12.22%
EPS Next 5Y7.94%
Revenue 1Y (TTM)-3.1%
Revenue growth 3Y4.31%
Revenue growth 5YN/A
Sales Q2Q%-0.31%
Revenue Next Year1.22%
Revenue Next 2Y2.83%
Revenue Next 3Y3.48%
Revenue Next 5Y3.14%
EBIT growth 1Y-33.42%
EBIT growth 3Y-0.36%
EBIT growth 5YN/A
EBIT Next Year51.65%
EBIT Next 3Y21.42%
EBIT Next 5Y14.93%
FCF growth 1Y-48.94%
FCF growth 3Y-7.48%
FCF growth 5YN/A
OCF growth 1Y-34.04%
OCF growth 3Y7.55%
OCF growth 5YN/A